Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The tyrosine kinase oncogenic pathway refers to a group of signaling cascades driven by the activity of tyrosine kinases. These pathways are central regulators of cell growth, differentiation, metabolism, and apoptosis. Mutations or dysregulation can lead to constitutive activation and drive oncogenesis (cancer development).
Inhibition of tyrosine kinase activity, blocking downstream signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tyrosine Kinase Oncogenic Pathway.